The ASM is a member of the Clinical Laboratory Standards Institute (CLSI). CLSI’s mission is to develop best practices in clinical and laboratory testing and promote their use throughout the world, using a consensus-driven process that balances the viewpoints of industry, government, and the health care professions. The ASM has a delegate to the CLSI, responsible for attending Committee meetings and voting on new guidelines on behalf of ASM. Susan Sharp, Ph.D., is ASM’s delegate and Stephen Cavalieri, Ph.D., is ASM’s alternate delegate.
- January 2011 CLSI Meeting Summary
- June 2010 CLSI Meeting Summary
- January 2010 CLSI Meeting Summary
- June 2009 CLSI Meeting Summary
- January 2009 CLSI Meeting Summary
August 25, 2010 – Opinion Articles on CLSI Changes to Cephalosporin breakpoints with the Enterobacteriaceae
Opinion articles were written by two experts in clinical microbiology who are both very familiar with the CLSI and the process that led up to the 2010 change in the cephalosporin breakpoints with the Enterobacteriaceae . These articles represent the PRO and CON assessments of the CLSI changes and are referenced for your further investigation. These opinion articles were reviewed by the PSAB Committee on Laboratory Practices. The Committee on Laboratory Practices thanks the authors, Paul C. Schreckenberger, Ph.D., and Stephen G. Jenkins, Ph.D., for their contribution to the understanding of this issue.
CLSI Changes to Cephalosporin breakpoints with the Enterobacteriaceae - PRO
CLSI Changes to Cephalosporin breakpoints with the Enterobacteriaceae - CON
For more information:
Clinical Laboratory Standards Institute